Bridgewater Associates’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,970	Closed	-$416K	–	770
2022 Q4	$416K	Buy	+14,970	New	+$416K	﹤0.01%	738
2022 Q3	–	Sell	-8,660	Closed	-$255K	–	906
2022 Q2	$255K	Buy	8,660 +1,793	+26%	+$52.8K	﹤0.01%	957
2022 Q1	$221K	Buy	+6,867	New	+$221K	﹤0.01%	955